You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Nanoliter Lab-on-a-chip for Protein Crystallization

    SBC: ADVANCED LIQUID LOGIC            Topic: N/A

    DESCRIPTION (provided by applicant): The human genome contains at least 30,000 unique open reading frames that may yield >100,000 polypeptide products. These products assemble into more than a million biologically relevant structures or proteins of interest per organism. Crystallization and X-ray diffraction of these proteins is routinely performed to determine their 3D structure which needs to be ...

    SBIR Phase II 2006 Department of Health and Human ServicesNational Institutes of Health
  2. Nanoliter Lab-on-a-Chip for Blood Diagnostics

    SBC: ADVANCED LIQUID LOGIC            Topic: N/A

    DESCRIPTION (provided by applicant): Latrogenic blood loss or "bleeding into the laboratory" is an important reason for administration of small volume transfusions in very low birth weight premature 6infants. A direct correlation was found between the volume of blood drawn for diagnostics and subsequent volume transfused. In neonatal infants, there may not be enough collected blood sample to perfo ...

    SBIR Phase II 2006 Department of Health and Human ServicesNational Institutes of Health
  3. Single ply 3Dwoven Functionally Gradient Multi-Fiber / Multi-Matrix Composites with Thermal Management Systems

    SBC: 3TEX, Inc.            Topic: AF04249

    In composites, not only can properties vary with load direction, fiber based composites also offer the unique ability to tailor material properties locally. Localized matrix or fiber architecture changes can meet local mechanical, electrical, or thermal loads within a component or vehicle, without weight penalty or resort to additional external structures. In Phase I, the team used 3TEX 3-D wea ...

    SBIR Phase II 2006 Department of DefenseAir Force
  4. Novel Structural Joining Concepts Using 3-D Textile Preforms and Composites

    SBC: 3TEX, Inc.            Topic: AF05248

    Strength and durability of commonly used bonded and bolted composite-to-composite and composite-to-metal structural joints suffer from sharp geometry variations, mismatch of elastic moduli, Poisson’s ratios, coefficients of thermal expansion and thermal conductivity of the adherends, altogether causing high stress concentration and premature joint failure. The proposed work is focused on develop ...

    SBIR Phase II 2006 Department of DefenseAir Force
  5. Improved Orthopedic Implant Surface Coatings

    SBC: AFFINERGY, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): Many contemporary medical and dental therapies include the replacement or repair of tissues using materials such as metal. Currently there are at least 150,000 hip replacements, 300,000 knee replacements, and 500,000 dental implant procedures performed in the US each year (Kurtz, Mowat et al. 2005). These numbers are expected to increase as the baby boom gen ...

    SBIR Phase II 2006 Department of Health and Human ServicesNational Institutes of Health
  6. Computer-Based Training in TSF for Drug Abuse Counselors:Phase II

    SBC: CBT4CBT LLC            Topic: N/A

    DESCRIPTION (provided by applicant): Bridging the gap between science and practice continues as a major problem in the effective delivery of treatments for alcohol abuse and dependence. Twelve Step Facilitation, an empirically supported therapy, is well positioned to bridge this gap. That is, although TSF is a highly structured manual driven approach, its basic tenets are familiar to many counselo ...

    SBIR Phase II 2006 Department of Health and Human ServicesNational Institutes of Health
  7. Clinical Development a Therapeutic Agent for COPD

    SBC: BIOMARCK PHARMACEUTICALS, LTD            Topic: N/A

    Hypersecretion of mucus into the respiratory airways is a major contributing factor in several lung diseases, including chronic pulmonary disease (COPD), asthma, cystic fibrosis, and bronchiectasis. Despite the obvious medical importance, there presently are no effective therapies to control excess mucus secretion in these diseases, and very few potential therapeutic targets. We discovered that a ...

    SBIR Phase II 2006 Department of Health and Human ServicesNational Institutes of Health
  8. Ophthalmic Optical Coherence Tomography

    SBC: BIOPTIGEN, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): This Phase II Small Business Innovative Research application proposes to dramatically expand the commercial availability of optical coherence tomography (OCT) technology for pre-clinical human and animal research applications by commercializing Fourier-domain OCT (FD-OCT) technology and developing robust interfaces for retinal OCT imaging in a wide variety of s ...

    SBIR Phase II 2006 Department of Health and Human ServicesNational Institutes of Health
  9. Plasmonic Fluorescence Microarray Detection System

    SBC: CIENCIA INC            Topic: N/A

    DESCRIPTION (provided by applicant): The objective of this SBIR Phase II project is to develop a novel fluorescence detection technology for highly parallel microarray analysis that will provide dramatically increased fluorescence signals so that high-sensitivity detection can be achieved with an inexpensive CCD camera and low-cost disposable plastic chips. The technology is based on the phenomeno ...

    SBIR Phase II 2006 Department of Health and Human ServicesNational Institutes of Health
  10. IDENTIFICATION OF NEW ACETYL-COA CARBOXYLASE INHIBITORS

    SBC: CROPSOLUTION, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Acetyl-CoA carboxylase (ACC) catalyzes the first step in fatty acid biosynthesis and its product, malonyl-CoA, inhibits fatty acid oxidation. These functions make ACC a prime target for the development of therapeutics to treat obesity and type 2 diabetes. Knockout studies in mice, and animal studies with ACC inhibitors, have validated this approach. The most po ...

    SBIR Phase II 2006 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government